CIK 0000010795
- Large accelerated filer
BECTON DICKINSON & CO
Sign in to watch- Ticker
- BDX
- Exchange
- NYSE
- Industry
- Surgical & Medical Instruments & Apparatus
- FY end
- Sep 30
- Incorporated
- NJ
- Entity type
- Operating
- EIN
- 220760120
- Phone
- +1 201-847-6800
- Business address
- ONE BECTON DR, FRANKLIN LAKES, NJ, 07417-1880
- Open-market buys, last 90 days
- $0
- in 0 filings
- Open-market sales, last 90 days
- $688,650
- in 4 filings, $689K under 10b5-1 plans
Net −$688,650. Shares bought or sold at a price by officers, directors and 10% owners (Form 4 codes P and S). Grants, option exercises and tax withholding aren't counted.
Who's trading
90 days
| Date | Insider | Transaction | Shares | Price | Value | Owned after |
|---|---|---|---|---|---|---|
| 2022-08-09 | Polen Thomas E Jr Executive Vice President | Sale | −1,652 | $260.00 | $430K | 28,878 |
| 2022-08-09 | Polen Thomas E Jr Executive Vice President | Exercise or conversion · Stock Appreciation Rights | −3,825 | 0 | ||
| 2022-08-08 | Khichi Samrat S. EVP and General Counsel | Sale | −7,295 | $260.44 | $1.9M | 5,928 |
| 2022-07-29 | Jones Christopher Ian Montague Director | Grant or award · Rights to Common Stock Under 1996 Directors Deferral Plan | +109 | $244.31 | $27K | 8,768 |
| 2022-07-29 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under 1996 Directors Deferral Plan | +109 | $244.31 | $27K | 327 |
| 2022-07-08 | Grover Rishi EVP and Chief ISC Officer | Grant or award | +9,340 | 9,439 | ||
| 2022-07-01 | Spoerel Thomas J VP Controller & Chief Acct Off | Grant or award | +414 | 1,472 | ||
| 2022-07-01 | Spoerel Thomas J VP Controller & Chief Acct Off | Grant or award | +420 | 1,478 | ||
| 2022-06-17 | Lim James C Executive Vice President | Grant or award | +3,280 | 23,941 | ||
| 2022-06-07 | Spoerel Thomas J VP Controller & Chief Acct Off | Exercise or conversion | +1,026 | $147.68 | $152K | 2,070 |
| 2022-06-07 | Spoerel Thomas J VP Controller & Chief Acct Off | Returned to the company | −583 | $260.00 | $152K | 1,487 |
| 2022-06-07 | Spoerel Thomas J VP Controller & Chief Acct Off | Sale | −443 | $260.00 | $115K | 1,058 |
| 2022-06-07 | Spoerel Thomas J VP Controller & Chief Acct Off | Exercise or conversion · Stock Appreciation Rights | −1,026 | 0 | ||
| 2022-05-06 | Byington Carrie L Director | Grant or award · Rights to Common Stock Under 1996 Directors Deferral Plan | +107 | $255.00 | $27K | 215 |
| 2022-05-06 | Hickey David EVP & President, Life Sciences | Sale | −475 | $256.00 | $122K | 3,806 |
| 2022-05-06 | Jones Christopher Ian Montague Director | Grant or award · Rights to Common Stock Under 1996 Directors Deferral Plan | +107 | $255.00 | $27K | 8,659 |
| 2022-04-06 | Neal Shana Carol Chief Human Resources Officer | Grant or award | +7,525 | 7,599 | ||
| 2022-03-02 | Ezell Antoine C EVP, President, NA & CMO | Shares withheld for taxes | −610 | 7,325 | ||
| 2022-03-01 | Ezell Antoine C EVP, President, NA & CMO | Shares withheld for taxes | −276 | 7,935 | ||
| 2022-03-01 | Spoerel Thomas J VP Controller & Chief Acct Off | Shares withheld for taxes | −35 | 1,044 |
Page 21 of 28 · 548 trades